InvestorsHub Logo
Followers 80
Posts 24706
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Friday, 09/21/2018 11:25:27 AM

Friday, September 21, 2018 11:25:27 AM

Post# of 27624
PLX - .6799

Protalix BioTherapeutics: A Deterioration Trend in Patients' Kidney Function on Agalsidase Alfa Was Reversed to an Improvement Trend When Switched to Pegunigalsidase Alfa >PLX

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.